橘皮組織治療市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024年，全球橘皮組織治療市場規模達24億美元，預計到2034年將以10.7%的複合年成長率成長，達到65億美元。這得歸功於先進的非侵入性和微創治療手段日益普及，這些手段能夠為消費者提供更有效的解決方案，並最大程度縮短恢復期。此外，消費者對身體美學的認知度不斷提升，以及對更安全、微創治療方案的渴望，進一步推動了此類治療的需求。橘皮組織是常見的美容問題，常見於大腿、臀部和腹部，導致皮膚出現凹陷或腫塊。橘皮組織主要影響女性，老化、荷爾蒙失調和體重增加等多種因素均可誘發或加重橘皮組織。

此外，久坐不動、不良飲食和血液循環不良等生活方式因素也會導致脂肪團的形成。脂肪沉積物突破皮下結締組織，形成橘皮組織，導致皮膚表面凹凸不平。隨著橘皮組織發病率的上升，尤其是在肥胖和衰老人群中，人們對有效治療方法的需求也日益成長，這些方法可以減少脂肪團的可見度，並恢復更光滑、更緊緻的肌膚。專注於分解脂肪細胞、促進血液循環和促進膠原蛋白生成的療法越來越受歡迎。這些療法旨在重塑皮下脂肪的分佈，改善受影響區域的整體紋理和膚色。

市場主要細分為各種治療類型，包括非侵入性治療、微創治療和局部治療。其中，非侵入性治療佔最大市場佔有率，預計複合年成長率為11.1%，到2034年將達32億美元。這些非手術治療，例如雷射療法、聲波療法、射頻療法和超音波療法，因其無痛、易於使用和快速恢復而備受青睞。對於希望在不進行複雜手術的情況下減少脂肪團的個人來說，它們是一種首選方案。非侵入性治療方法不斷發展，各公司致力於改進這些方法，以滿足消費者對有效、舒適且低風險解決方案日益成長的需求。

2024年，硬性脂肪團市場規模達11億美元，預計2034年將達30億美元，複合年成長率達10.4%。硬性脂肪團的特點是組織緻密、纖維豐富，對傳統療法的療效更差，需要更先進的治療方法，例如雷射療法和射頻療法。隨著生活方式活躍的年輕人群中硬性脂肪團的盛行率不斷上升，推動了對這些專業療法的需求。這促使旨在解決這種更頑固脂肪團問題的創新有效療法的發展激增。

2024年，美國橘皮組織治療市場規模達7.637億美元，歸因於人群中橘皮組織發病率高、人們對現有治療方法的認知度不斷提高，以及對非侵入性治療方案的強烈偏好。此外，美國擁有完善的醫療基礎設施，並且注重美容和醫美治療，這刺激了對橘皮組織減少療法的需求。

全球橘皮組織治療市場中的公司正在採取產品創新、合作夥伴關係以及擴大地域覆蓋範圍等策略，以鞏固其市場地位。 Venus Concept、Soliton（艾伯維）和 Cynosure 等公司正致力於利用尖端技術增強其產品線，以滿足日益成長的有效治療需求。與醫療保健提供者和美容診所的合作，以及策略性行銷活動，使這些公司得以擴大其業務範圍。此外，他們還在研發方面投入資金，以創造更先進、更有效率的橘皮組織治療方法，確保其在市場上保持競爭優勢。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 人們對美容手術的認知和需求不斷增加
    • 非侵入性和微創技術日益進步
    • 越來越傾向於非侵入性和微創手術
    • 擴大皮膚科和美容診所
  • 產業陷阱與挑戰
    • 治療費用高
    • 對潛在副作用的擔憂日益增加
    • 嚴格的法規核准
• 成長潛力分析
• 管道分析
• 技術格局
• 監管格局
• 川普政府關稅
  • 對貿易的影響
    • 貿易量中斷
    • 報復措施
  • 對產業的影響
    • 供給側影響（原料）
      • 主要材料價格波動
      • 供應鏈重組
      • 生產成本影響
    • 需求面影響（售價）
      • 價格傳導至終端市場
      • 市佔率動態
      • 消費者反應模式
  • 受影響的主要公司
  • 策略產業反應
    • 供應鏈重組
    • 定價和產品策略
    • 政策參與
  • 展望與未來考慮
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按橘皮組織類型，2021 - 2034 年

• 主要趨勢
• 硬脂肪團
• 軟脂肪團
• 水腫性橘皮組織

第6章：市場估計與預測：按治療類型，2021 - 2034 年

• 主要趨勢
• 非侵入性治療
  • 雷射治療
  • 聲波療法
  • 射頻治療
  • 超音波治療
• 微創治療
  • 切開術
  • 冷凍溶脂
  • 其他微創治療
• 局部治療
• 口服補充劑

第7章：市場估計與預測：依性別，2021 - 2034 年

• 主要趨勢
• 女性
• 男性

第8章：市場估計與預測：按年齡層，2021 - 2034 年

• 主要趨勢
• 30歲以下
• 30 - 50年
• 50歲以上

第9章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院
• 皮膚科診所
• 美容與健康中心
• 家庭使用

第10章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：公司簡介

• Air Sculpt
• Alma Lasers
• Bausch Health
• Bionov
• Candela
• Cutera
• Cynosure
• El En. Group
• Endo International
• Hologic
• Merz Pharma
• Mesoestetic
• Revelle Aesthetics
• Sirona Biochem
• Soliton (Abbvie)
• Ulthera
• Zimmer Aesthetics

The Global Cellulite Treatment Market was valued at USD 2.4 billion in 2024 and is estimated to grow at a CAGR of 10.7% to reach USD 6.5 billion by 2034, driven by the increasing popularity of advanced non-invasive and minimally invasive treatments, which offer consumers more effective solutions with minimal downtime. Additionally, heightened consumer awareness regarding body aesthetics and the desire for safer, less invasive treatments have further fueled the demand for these procedures. Cellulite is a widespread cosmetic concern, commonly seen around the thighs, hips, and abdomen, resulting in the appearance of dimpled or lumpy skin. It primarily affects women and can be triggered or worsened by various factors, such as aging, hormonal imbalances, and weight gain.

Additionally, lifestyle factors like a sedentary routine, poor diet, and insufficient circulation can contribute to its development. As cellulite forms when fat deposits push through the connective tissue beneath the skin, it creates an uneven surface appearance. With the rising incidence of cellulite, especially among those affected by obesity and the aging process, there is an increased demand for effective treatments that can reduce its visibility and restore smoother, firmer skin. Treatments that focus on breaking down fat cells, stimulating blood flow, and boosting collagen production are gaining popularity. These treatments aim to reshape the fat distribution beneath the skin, improving the overall texture and tone of the affected areas.

The market is primarily segmented into various treatment types, including non-invasive, minimally invasive, and topical treatments. Among these, the non-invasive segment holds the largest market share, projected to grow at a CAGR of 11.1%, reaching USD 3.2 billion by 2034. These non-surgical treatments, such as laser therapy, acoustic wave therapy, radiofrequency therapy, and ultrasound therapy, are highly favored due to their painless nature, ease of use, and rapid recovery times. They provide a preferred option for individuals looking to minimize cellulite without undergoing extensive procedures. The non-invasive treatments continue to evolve, with companies focusing on improving these methods to meet increasing consumer demand for effective, comfortable, and low-risk solutions.

The hard cellulite segment was valued at USD 1.1 billion in 2024 and is expected to reach USD 3 billion by 2034, growing at a CAGR of 10.4%. Hard cellulite, which is characterized by dense, fibrous tissue and is more resistant to traditional treatments, requires more advanced treatment methods, such as laser therapy and radiofrequency. The increasing prevalence of hard cellulite among younger individuals who lead active lifestyles has driven demand for these specialized treatments. This has led to a surge in the development of innovative and effective therapies aimed at addressing this more stubborn form of cellulite.

U.S. Cellulite Treatment Market was valued at USD 763.7 million in 2024, attributed to the high occurrence of cellulite in the population, the growing awareness of available treatments, and the strong preference for non-invasive options. Furthermore, the U.S. benefits from a well-established healthcare infrastructure and a focus on cosmetic and aesthetic treatments, which have boosted the demand for cellulite reduction therapies.

Companies in the Global Cellulite Treatment Market are adopting strategies such as product innovation, partnerships, and expanding their geographic presence to strengthen their market position. Firms like Venus Concept, Soliton (AbbVie), and Cynosure are focusing on enhancing their product offerings with cutting-edge technology to meet the growing demand for effective treatments. Collaborations with healthcare providers and cosmetic clinics, along with strategic marketing campaigns, have enabled these companies to expand their reach. Additionally, they are investing in research and development to create more advanced and efficient cellulite treatments, ensuring they maintain a competitive edge in the market.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing awareness and demand for aesthetic procedures
    • 3.2.1.2 Growing advancement in non-invasive and minimally invasive technologies
    • 3.2.1.3 Increasing preference for non-invasive and minimally invasive procedures
    • 3.2.1.4 Expansion of dermatology and aesthetic clinics
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High treatment costs
    • 3.2.2.2 Growing concerns related to potential side effects
    • 3.2.2.3 Strict regulatory approvals
• 3.3 Growth potential analysis
• 3.4 Pipeline analysis
• 3.5 Technology landscape
• 3.6 Regulatory landscape
• 3.7 Trump administration tariffs
  • 3.7.1 Impact on trade
    • 3.7.1.1 Trade volume disruptions
    • 3.7.1.2 Retaliatory measures
  • 3.7.2 Impact on the Industry
    • 3.7.2.1 Supply-side impact (raw materials)
      • 3.7.2.1.1 Price volatility in key materials
      • 3.7.2.1.2 Supply chain restructuring
      • 3.7.2.1.3 Production cost implications
    • 3.7.2.2 Demand-side impact (selling price)
      • 3.7.2.2.1 Price transmission to end markets
      • 3.7.2.2.2 Market share dynamics
      • 3.7.2.2.3 Consumer response patterns
  • 3.7.3 Key companies impacted
  • 3.7.4 Strategic industry responses
    • 3.7.4.1 Supply chain reconfiguration
    • 3.7.4.2 Pricing and product strategies
    • 3.7.4.3 Policy engagement
  • 3.7.5 Outlook and future considerations
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Cellulite Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Hard cellulite
• 5.3 Soft cellulite
• 5.4 Edematous cellulite

Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Non-invasive treatment
  • 6.2.1 Laser treatment
  • 6.2.2 Acoustic wave therapy
  • 6.2.3 Radiofrequency therapy
  • 6.2.4 Ultrasound therapy
• 6.3 Minimally invasive treatment
  • 6.3.1 Subcision
  • 6.3.2 Cryolipolysis
  • 6.3.3 Other minimally invasive treatment
• 6.4 Topical treatments
• 6.5 Oral supplements

Chapter 7 Market Estimates and Forecast, By Gender, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Female
• 7.3 Male

Chapter 8 Market Estimates and Forecast, By Age Group, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Below 30 years
• 8.3 30 - 50 years
• 8.4 Above 50 years

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Dermatology clinics
• 9.4 Beauty and wellness centers
• 9.5 Home-use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 India
  • 10.4.3 Japan
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Air Sculpt
• 11.2 Alma Lasers
• 11.3 Bausch Health
• 11.4 Bionov
• 11.5 Candela
• 11.6 Cutera
• 11.7 Cynosure
• 11.8 El En. Group
• 11.9 Endo International
• 11.10 Hologic
• 11.11 Merz Pharma
• 11.12 Mesoestetic
• 11.13 Revelle Aesthetics
• 11.14 Sirona Biochem
• 11.15 Soliton (Abbvie)
• 11.16 Ulthera
• 11.17 Zimmer Aesthetics